Yep, nailed it Grant. Well done. Provides breathing space for the business but this just puts shareholders further out of the equation. Lenders providing these things are going to want it all or close to it.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%